EDVANYSEBeveragesFiscal year ends December 31

Endovia Health Sciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.14−0.01 (-7.53%)

Close on Oct 19, 2026

Community

Notes and questions about Endovia Health Sciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Endovia Health Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Aug 19, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EDVA.

Revenue growth-90.9% · median -15.3%

Gross margin34.7% · median 16.6%

Operating margin-18486.6% · median -87.9%

Net margin-23653.4% · median 22.0%

Advertisement
300 × 250